Global

Inherited Bleeding Disorders

About These Disorders
Product List
Resources


This Global website is not intended to represent or suggest that particular products are approved or authorized in any particular jurisdiction. You should not construe anything on this website as a promotion or solicitation for any product or service, or as suggesting that a product or service be used where it is not approved or authorized by applicable law and regulation in a particular country, territory, or jurisdiction. To learn which products are approved or authorized in particular countries, please consult the appropriate country-specific website.

Treatment Area Product Name Generic Name Product Description
von Willebrand Disease; Hemophilia A Humate-P®, Haemate® P Biostate® Voncento® Human von Willebrand factor/FVIII complex Freeze-dried von Willebrand factor and FVIII concentrate
von Willebrand Disease; Hemophilia A Stimate®, Octostim® Desmopressin Synthetic desmopressin acetate nasal spray
Hemophilia A AFSTYLA ® Antihemophilic Factor (Recombinant), Single Chain Lyophilized powder Coagulation Factor VIII (Recombinant), Single Chain
Hemophilia A Helixate®FS, Helixate® NexGen Recombinant coagulation factor VIII Freeze-dried, recombinant factor VIII
Hemophilia A Monoclate-P® Human coagulation factor VIII Freeze-dried, monoclonal antibody purified factor VIII concentrate
Hemophilia A Beriate® Human coagulation factor VIII Freeze-dried, factor VIII concentrate
Hemophilia B IDELVION® Recombinant Coagulation Factor IX Lyophilized powder Coagulation Factor IX (Recombinant) Albumin Fusion Protein
Hemophilia B Mononine® Human coagulation Factor IX Freeze-dried monoclonal antibody purified factor IX concentrate
Hemophilia B Berinin® P Human coagulation Factor IX Freeze-dried factor IX concentrate
Factor I (FI) deficiency RiaSTAP®, Haemocomplettan® P Human fibrinogen Freeze-dried FI concentrate
Congenital factor IX deficiency Factor X P Behring Human coagulation factors IX and X Freeze-dried human coagulation factors IX and X concentrate

Congenital Factor XIII deficiency and resulting hemorrhagic diathesis, hemorrhages and disturbances in wound healing

Hemorrhagic diatheses due to acquired Factor XIII deficiency

Disturbed wound healing, especially ulcus cruris, after large surgery or injuries

Fibrogammin-P Human coagulation Factor XIII Freeze-dried Factor XIII concentrate for IV administration
Congenital Factor XIII deficiency Corifact®
Cluvot®
Cluviat®
Human coagulation Factor XIII Freeze-dried Factor XIII concentrate for IV administration
Therapy and prophylaxis of hemorrhagic diatheses in:

  • Congenital hypo-, dys- or afibrinogenemia
  • Acquired hypofibrinogenemia resulting from disorders of synthesis in cases of severe liver parenchyma damage, increased intravascular consumption (e.g. as a result of disseminated intravascular coagulation), hyperfibrinolysis, or increased loss
Haemocomplettan® P Human fibrinogen Freeze-dried fibrinogen (factor I) concentrate
Bleeding in patients with congenital hypo-, or afibrinogenemia with bleeding tendency RiaSTAP® Human fibrinogen Freeze-dried fibrinogen (factor I) concentrate

 

*RiaSTAPĀ® is currently only licensed for congenital fibrinogen (factor I) deficiency in the US and Europe.

Octostim® is a trademark of Ferring GmbH.

Share
LinkedIn Twitter Facebook Google+